PARIS, FRANCE, 3 October 2023 – Ipsen announced today that its partner Galderma has confirmed receipt from the FDA of a Complete Response Letter related to its Biologics License Application for.
PARIS, FRANCE, 3 October 2023 – Ipsen ((Euronext: IPN, OTC:IPSEY) announced today that its partner Galderma has confirmed receipt from the FDA of a Complete Response Letter related to its Biologics License Application
Ipsen updates on QM-1114 regulatory process itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Ipsen updates on QM-1114 regulatory process finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.